MedPath

A study to see the effect of Dhatryadi lepa as compared to Shalmalikantak lepa in treatment of acne vulgaris.

Phase 1
Completed
Conditions
Patient should be in a good healthy condition. They should not have any hypertensive or diabetic disorder .
Registration Number
CTRI/2020/02/023408
Lead Sponsor
Dr Priyanka Yadav
Brief Summary

The aim of the study is to find the effectiveness of Dhatryadi lepa and shalmalikantak lepa in the management of Acne vulgaris.

The study will be conducted in two groups. Group A will be given Dhatryadi lepa. Group B will be given Shalmalikantak lepa.

For both the group of patients medicine will be given for 28 days and follow up will be taken and result will be done using proper statistical methods.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients suffering from Acne vulgaris.

Exclusion Criteria
  • Patient suffering from other skin diseases.
  • Patient suffering from Chronic illness and infective diseases like malignant conditions and skin tuberculosis.
  • Acne produced due to side effect of any drug applied earlier.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To get cured of Acne vulgaris.The cure shall be assessed in 4 follow ups in 28 days.
Secondary Outcome Measures
NameTimeMethod
Getting cured of the marked symptoms on the skin adding to the cosmetic effect.28 days

Trial Locations

Locations (1)

Dr. Dy Patil college of Ayurveda and research centre

🇮🇳

Pune, MAHARASHTRA, India

Dr. Dy Patil college of Ayurveda and research centre
🇮🇳Pune, MAHARASHTRA, India
Priyanka Yadav
Principal investigator
7718015502
priyaay25@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.